Advances in medical diagnosis, treatment, and care (AMDTC) book series,
Journal Year:
2024,
Volume and Issue:
unknown, P. 453 - 482
Published: Dec. 13, 2024
Gastrointestinal
tract
harbours
a
very
complex
and
dynamic
community
of
microorganisms
known
as
the
'gut
microbiota'.
These
microbes
are
involved
in
various
critical
physiological
processes,
including
digestion
biomolecules,
synthesis
vitamins,
modulation
immune
system,
protection
against
pathogens.
This
chapter
provides
comprehensive
overview
gut
brain
axis.
The
delves
into
role
microbial
metabolites
like
short
chain
fatty
acids,
tryptophan
bile
acids
neuronal
neurotransmitter
functioning.
Cytokine
release
system
activation
can
potentially
change
microbiota
composition.
psychological
stress
reducing
beneficial
bacteria
increasing
pathogenic
composition
has
been
detailed.
Psychological
lead
to
these
consequences
by
altering
permeability
intestinal
cells.
effect
compromised
on
health
through
altered
activity
discussed.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3148 - 3148
Published: March 28, 2025
Oxidative
stress
(OS)
and
gut
microbiota
are
crucial
factors
influencing
human
health,
each
playing
a
significant
role
in
the
development
progression
of
chronic
diseases.
This
review
provides
comprehensive
analysis
complex
interplay
between
these
two
factors,
focusing
on
how
an
imbalance
reactive
oxygen
species
(ROS)
antioxidants
leads
to
OS,
disrupting
cellular
homeostasis
contributing
range
conditions,
including
metabolic
disorders,
cardiovascular
diseases,
neurological
cancer.
The
microbiota,
diverse
community
microorganisms
residing
gastrointestinal
tract,
is
essential
for
regulating
immune
responses,
pathways,
overall
health.
Dysbiosis,
composition,
closely
associated
with
inflammation,
dysfunction,
various
highlights
influences
influenced
by
complicating
pathophysiology
many
conditions.
Furthermore,
emerging
evidence
has
identified
extracellular
vesicles
(EVs)
as
critical
facilitators
crosstalk
OS
microbiota.
EVs
also
play
signaling
host
tissues,
modulating
processes.
function
holds
promise
targeted
therapies
aimed
at
restoring
microbial
balance
mitigating
OS.
Personalized
therapeutic
approaches,
probiotics,
antioxidants,
fecal
transplantation-based
strategies,
can
be
used
address
OS-related
diseases
improve
health
outcomes.
Nonetheless,
further
research
needed
study
molecular
mechanisms
underlying
interactions
potential
innovative
interventions
offer
novel
strategies
managing
enhancing
Microbiome,
Journal Year:
2025,
Volume and Issue:
13(1)
Published: April 2, 2025
Abstract
Background
Alterations
in
the
composition
and
function
of
intestinal
microbiota
have
been
observed
organismal
aging
across
a
broad
spectrum
animal
phyla.
Recent
findings,
which
derived
mostly
simple
models,
even
established
causal
relationship
between
age-related
microbial
shifts
lifespan,
suggesting
microbiota-directed
interventions
as
potential
tool
to
decelerate
processes.
To
test
whether
life-long
microbiome
rejuvenation
strategy
could
delay
or
prevent
non-ruminant
mammals,
we
performed
recurrent
fecal
transfer
(FMT)
mice
throughout
life.
Transfer
material
was
either
from
8-week-old
(young
microbiome,
yMB)
animals
same
age
recipients
(isochronic
iMB)
control.
Motor
coordination
strength
were
analyzed
by
rotarod
grip
tests,
barrier
serum
LAL
assay,
transcriptional
responses
single-cell
RNA
sequencing,
community
properties
16S
rRNA
gene
profiling
metagenomics.
Results
Colonization
with
yMB
improved
permeability
compared
iMB.
encoded
fewer
pro-inflammatory
factors
altered
metabolic
pathways
favoring
oxidative
phosphorylation.
Ecological
interactions
among
bacteria
more
antagonistic
than
iMB
implying
stable
communities.
Single-cell
sequencing
analysis
mucosa
revealed
salient
shift
cellular
phenotypes
group
markedly
increased
ATP
synthesis
mitochondrial
well
decrease
age-dependent
mesenchymal
hallmark
transcripts
enterocytes
TA
cells,
but
reduced
inflammatory
signaling
macrophages.
Conclusions
Taken
together,
demonstrate
that
repeated
young
processes
including
coordinative
ability
(rotarod),
permeability,
both
profiles
mainly
macrophages
also
other
immune
cells.
The
gut
biome,
a
complex
ecosystem
of
micro-
and
macro-organisms,
plays
crucial
role
in
human
health.
A
disruption
this
evolutive
balance,
particularly
during
early
life,
can
lead
to
immune
dysregulation
inflammatory
disorders.
‘Biome
repletion’
has
emerged
as
potential
therapeutic
approach,
introducing
live
microbes
or
helminth-derived
products
restore
balance.
While
helminth
therapy
shown
some
promise,
significant
challenges
remain
optimizing
clinical
trials.
Factors
such
patient
genetics,
disease
status,
species,
the
optimal
timing
dosage
their
metabolites
must
be
carefully
considered
train
system
effectively.
We
aim
discuss
how
helminths
induce
trained
immunity
prospective
treat
autoimmune
diseases.
molecular
repertoire
excretory/secretory
(ESPs),
which
includes
proteins,
peptides,
lipids,
RNA-carrying
extracellular
vesicles
(EVs),
underscores
modulate
innate
cells
hematopoietic
stem
cell
precursors.
Mimicking
natural
delivery
mechanisms
like
synthetic
exosomes
could
revolutionize
EV-based
therapies
production
ESP
will
for
translation
into
applications.
By
deciphering
harnessing
products’
diverse
modes
action,
we
unleash
full
pave
way
innovative
treatments.
MedComm,
Journal Year:
2025,
Volume and Issue:
6(5)
Published: April 18, 2025
ABSTRACT
Dysbiosis
refers
to
the
disruption
of
gut
microbiota
balance
and
is
pathological
basis
various
diseases.
The
main
pathogenic
mechanisms
include
impaired
intestinal
mucosal
barrier
function,
inflammation
activation,
immune
dysregulation,
metabolic
abnormalities.
These
involve
dysfunctions
in
gut–brain
axis,
gut–liver
others
cause
broader
effects.
Although
association
between
diseases
caused
by
dysbiosis
has
been
extensively
studied,
many
questions
remain
regarding
specific
treatment
strategies.
This
review
begins
examining
causes
summarizes
potential
representative
imbalance.
It
integrates
clinical
evidence
explore
preventive
therapeutic
strategies
targeting
emphasizing
importance
understanding
dysbiosis.
Finally,
we
summarized
development
artificial
intelligence
(AI)
research
suggested
that
it
will
play
a
critical
role
future
studies
on
combining
multiomics
technologies
AI
further
uncover
complex
drive
personalized
Frontiers in Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: Sept. 26, 2024
In
recent
years,
the
incidence
of
neurodegenerative
diseases
(NDs)
has
gradually
increased
over
past
decades
due
to
rapid
aging
global
population.
Traditional
research
had
difficulty
explaining
relationship
between
its
etiology
and
unhealthy
lifestyle
diets.
Emerging
evidence
proved
that
pathogenesis
may
be
related
changes
gut
microbiota’s
composition.
Metabolism
microbiota
insidious
far-reaching
effects
on
provides
new
directions
for
disease
intervention.
Here,
we
delineated
basic
diseases,
highlighting
metabolism
in
also
focusing
treatments
NDs
based
microbiota.
Our
review
provide
novel
insights
neurodegeneration
approach
a
broadly
applicable
basis
clinical
therapies
diseases.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 11, 2024
There
is
increasing
evidence
that
the
intestinal
microbiota
plays
an
integral
role
in
disease
pathogenesis
and
treatment.
Specifically,
significantly
influences
pharmacokinetics
pharmacodynamics
of
orally
administered
drugs
through
direct
involvement
drug
metabolism
and,
consequently,
bioavailability.
However,
gut
also
exerts
immunoregulatory
effects
on
liver-the
organ
primarily
responsible
for
metabolism-thereby
indirectly
impacting
body's
capacity
to
metabolise
process
drugs.
Individual
differences
this
pathway
substantially
contribute
variability
clinical
treatment
outcomes
observed
between
patients.
This
review
examines
impact
liver
immune
responses,
as
triggered
by
microbiota,
activity
drug-metabolising
enzymes
discusses
implications
precision
medicine.
Inorganics,
Journal Year:
2024,
Volume and Issue:
12(12), P. 308 - 308
Published: Nov. 26, 2024
Recently,
we
discovered
and
proved
the
essentiality
of
organic
boron
species
(OBS),
such
as
borate–pectic
polysaccharides
borate–phenolic
esters,
for
healthy
symbiosis
(HS)
between
microbiota
human/animal
(H/A)
host.
The
OBS
will
provide
new
options
B
supplementation
in
H/A
nutrition
a
long
life.
New
knowledge
on
naturally
occurring
microbiota-accessible
borate
HS
host
allow
use
natural
B-based
dietary
supplements
to
target
microbiome
(the
gut,
skin,
oral,
scalp,
vaginal
microbiome).
In
literature,
there
is
evidence
that
certain
bacteria
need
(autoinducer-2
borate)
communication
our
preliminary
data
show
takes
place
when
colonic
mucus
gel
layer
contains
B.
Subsequently,
become
novel
prebiotic
candidates
colon
foods.
Advances in medical diagnosis, treatment, and care (AMDTC) book series,
Journal Year:
2024,
Volume and Issue:
unknown, P. 453 - 482
Published: Dec. 13, 2024
Gastrointestinal
tract
harbours
a
very
complex
and
dynamic
community
of
microorganisms
known
as
the
'gut
microbiota'.
These
microbes
are
involved
in
various
critical
physiological
processes,
including
digestion
biomolecules,
synthesis
vitamins,
modulation
immune
system,
protection
against
pathogens.
This
chapter
provides
comprehensive
overview
gut
brain
axis.
The
delves
into
role
microbial
metabolites
like
short
chain
fatty
acids,
tryptophan
bile
acids
neuronal
neurotransmitter
functioning.
Cytokine
release
system
activation
can
potentially
change
microbiota
composition.
psychological
stress
reducing
beneficial
bacteria
increasing
pathogenic
composition
has
been
detailed.
Psychological
lead
to
these
consequences
by
altering
permeability
intestinal
cells.
effect
compromised
on
health
through
altered
activity
discussed.